Marine compounds for the therapeutic treatment of neurological disorders

Author： Alonso Diana Castro Ana Martinez Ana

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.10, 2005-10, pp. : 1377-1386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroimmunophilin ligands: evaluation of their therapeutic potential for the treatment of neurological disorders

By Gold B.G.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2331-2342

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Strategy of Erythropoietin in Neurological Disorders

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Davunetide: Peptide Therapeutic in Neurological Disorders

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2591-2598

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Potential of Statins in Neurological Disorders

Current Medicinal Chemistry, Vol. 14, Iss. 1, 2007-01 ,pp. : 103-112

Bentham Science Publishers

Access to resources Recommend Favorite

Combining Polymeric Devices and Stem Cells for the Treatment of Neurological Disorders: A Promising Therapeutic Approach

Current Drug Targets, Vol. 6, Iss. 1, 2005-02 ,pp. : 81-96

Bentham Science Publishers

Access to resources Recommend Favorite